Clinical and Molecular Hepatology10.3350/cmh.2013.19.4.3252013194325KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease,,
Clinical Liver Disease10.1002/cld.722201811481-81The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases,
Clinical and Molecular Hepatology10.3350/cmh.2013.19.3.2162013193216KASL Clinical Practice Guidelines: Management of Alcoholic Liver Disease,,
Clinical Liver Disease10.1002/cld.66201214129-130Management of nonalcoholic fatty liver disease in childrenJean P. Molleston,
Clinical Liver Disease10.1002/cld.75201214125-128Pediatric nonalcoholic fatty liver disease: Prevalence, diagnosis, risk factors, and managementStavra A. Xanthakos, Rohit Kohli,
Clinical Liver Disease10.1002/cld.12162022196222-226The diagnosis and management of nonalcoholic fatty liver disease: A patient‐friendly summary of the 2018 AASLD guidelinesConnor Griffin, Ranjeeta Bahirwani,,
Clinical and Molecular Hepatology10.3350/cmh.2014.20.2.89201420289KASL clinical practice guidelines: Management of Hepatitis C,,
Clinical Liver Disease10.1002/cld.65201214104-107Nonalcoholic fatty liver disease: Indications for liver biopsy and noninvasive biomarkersMazen Noureddin, Rohit Loomba,
Clinical and Molecular Hepatology10.3350/cmh.2016.22.1.76201622176-139KASL clinical practice guidelines: management of hepatitis C,,
Clinical Liver Disease10.1002/cld.27201214112-113Natural history of nonalcoholic fatty liver diseaseRohini Mehta, Zobair M. Younossi,